Are clinical trials of cell transplantation for Duchenne muscular dystrophy ethical?
D000293:Adolescent; D000328:Adult; D002648:Child; D017041:Ethics Committees; D028744:Ethics Committees, Research; D005069:Evaluation Studies as Topic; D035082:Federal Government; D015316:Genetic Therapy; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D020388:Muscular Dystrophy, Duchenne; D018579:Patient Selection; D004364:Pharmaceutical Preparations; D012106:Research; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D013315:Stress, Psychological; D036302:Therapeutic Human Experimentation; D020458:Third-Party Consent; D016378:Tissue Transplantation; D014481:United States; D014486:United States Food and Drug Administration
Biomedical and Behavioral Research; Health Care and Public Health; Professional Patient Relationship